U.S., May 9 -- ClinicalTrials.gov registry received information related to the study (NCT07574957) titled 'Prediction of Peritoneal Dissemination of Digestive Tumors Through the Study of Circulating Tumor DNA' on March 10.
Brief Summary: The peritoneum is a relatively frequent metastatic site in digestive tumors (colon, stomach, pancreas) and is characterized by a poorer prognosis compared with other metastatic sites such as the lung or liver. Its dissemination pathway is complex and most often involves crossing the hemato-peritoneal barrier. This type of metastasis is difficult to visualize on imaging at an early stage, and surgical exploration may be required. In gastric cancer in particular, exploratory laparoscopy is part of the initia...